Moreover, we speculate about the potential implications of the opposing functions of IL-1 family members for treating chronic intestinal inflammation and inflammation-associated colorectal cancer (CRC), as well as in designing more efficacious strategies for the prevention and treatment of these devastating GI pathologies. This evidence concerns the gene IL1B and colorectal carcinoma.